The maintenance of the body weight at a stable level is a major determinant in keeping the higher animals and mammals survive. Th e body weight depends on the balance between the energy intake and energy expenditure. Increased food intake over the energy expenditure of prolonged time period results in an obesity. Th e obesity has become an important worldwide health problem, even at low levels. The obesity has an evil effect on the health and is associated with a shorter life expectancy. A complex of central and peripheral physiological signals is involved in the control of the food intake. Centrally, the food intake is controlled by the hypothalamus, the brainstem, and endocannabinoids and peripherally by the satiety and adiposity signals. Comprehension of the signals that control food intake and energy balance may open a new therapeutic approaches directed against the obesity and its associated complications, as is the insulin resistance and others. In conclusion, the present review summarizes the current knowledge about the complex system of the peripheral and central regulatory mechanisms of food intake and their potential therapeutic implications in the treatment of obesity.
If the inline PDF is not rendering correctly, you can download the PDF file here.
Abdel-Hakim SM Ibrahim MY Ibrahim HM Ibrahim MM. The effect of ghrelin antagonist (D-Lys3) GHRP-6 on ovariectomy-induced obesity in adult female albino rats. Endocr Regul 48 126-134 2014.
Adachi S Takiguchi S Okada K Yamamoto K Yamasaki M Miyata H Nakajima K Fujiwara Y Hosoda H Kangawa K Mori M Doki Y. Eff ects of ghrelin administration aft er total gastrectomy: a prospective randomized placebo-controlled phase II study. Gastroenterology 138 1312-1320 2010.
Ahima RS Lazar MA. Adipokines and the peripheral and neural control of energy balance. Mol Endocrinol 22 1023-1031 2008.
Aja S Sahandy S Ladenheim EE Schwartz GJ Moran TH. Intracerebroventricular CART peptide reduces food intake and alters motor behavior at a hindbrain site. Am J Physiol Regul Integr Comp Physiol 281 R1862-R1867 2001.
Alen F Ramirez-Lopez MT Gomez de Heras R Rodriguez de Fonseca F Orio L. Cannabinoid receptors and cholecystokinin in feeding inhibition. Vitam Horm 92 165-196 2013.
Alvarez-Castro P Pena L Cordido F. Ghrelin in obesity physiological and pharmacological considerations. Mini Rev Med Chem 13 541-552 2013.
Arnold M Mura A Langhans W Geary N. Gut vagal aff erents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat. J Neurosci 26 11052-11060 2006.
Baggio LL Huang Q Brown TJ Drucker DJ. Oxyntomodulin and glucagon-like peptide-1 diff erentially regulate murine food intake and energy expenditure. Gastroenterology 127 546-558 2004.
Baggio LL Drucker DJ. Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight. J Clin Invest 124 4223-4226 2014.
Bagnol D Lu XY Kaelin CB Day HE Ollmann M Gantz I Akil H Barsh GS Watson SJ. Anatomy of an endogenous antagonist: relationship between Agouti-related protein and proopiomelanocortin in brain. J Neurosci 19 RC26 1999.
Banerjee RR Rangwala SM Shapiro JS Rich AS Rhoades B Qi Y Wang J Rajala MW Pocai A Scherer PE Steppan CM Ahima RS Obici S Rossetti L Lazar MA. Regulation of fasted blood glucose by resistin. Science 303 1195-1198 2004.
Batterham RL Le Roux CW Cohen MA Park AJ Ellis SM Patterson M Frost GS Ghatei MA Bloom SR. Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab 88 3989-3992 2003.
Benelam B. Satiation satiety and their eff ects on eating behaviour. Nutr Bull 34 126-173 2009.
Bennetzen MF Wellner N Ahmed SS Ahmed SM Diep TA Hansen HS Richelsen B Pedersen SB. Investigations of the human endocannabinoid system in two subcutaneous adipose tissue depots in lean subjects and in obese subjects before and aft er weight loss. Inter J Obes 35 1377-1384 2011.
Bermudez-Silva FJ Viveros MP McPartland JM Rodriguez de Fonseca F. The endocannabinoid system eating behavior and energy homeostasis: the end or a new beginning? Pharmacol Biochem Behav 95 375-382 2010.
Bermudez-Silva FJ Cardinal P Cota D. Th e role of the endocannabinoid system in the neuroendocrine regulation of energy balance. J Psychopharmacol 26 114-124 2012.
Bernardis LL Bellinger LL. Th e dorsomedial hypothalamic nucleus revisited: 1986 update. Brain Res 434 321-381 1987.
Blevins JE Baskin DG. Translational and therapeutic potential of oxytocin as an anti-obesity strategy: insights from rodents nonhuman primates and humans. Physiol Behav 152 438-449 2015.
Blevins JE Graham JL Morton GJ Bales KL Schwartz MW Baskin DG Havel PJ. Chronic oxytocin administration inhibits food intake increases energy expenditure and produces weight loss in fructose-fed obese rhesus monkeys. Am J Physiol Regul Integr Comp Physiol 308 R431-R438 2015.
Boey D Lin S Enriquez RF Lee NJ Slack K Couzens M Baldock PA Herzog H Sainsbury A. PYY transgenic mice are protected against diet-induced and genetic obesity. Neuropeptides 42 19-30 2008.
Boguszewski CL Paz-Filho G Velloso LA. Neuroendocrine body weight regulation: integration between fat tissue gastrointestinal tract and the brain. Endokrynol Pol 61 194-206 2010.
Bray GA York DA. Studies on food intake of genetically obese rats. Am J Physiol 223 176-179 1972.
Bray GA Smith SR DeJonge L de Souza R Rood J Champagne CM Laranjo N Carey V Obarzanek E Loria CM Anton SD Ryan DH Greenway FL Williamson D Sacks FM. Eff ect of diet composition on energy expenditure during weight loss: the POUNDS LOST Study. Int J Obes (Lond) 36 448-455 2012.
Broberger C De Lecea L Sutcliffe JG Hokfelt T. Hypocretin/Orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: Relationship to the neuropeptide Y and agouti gene-related protein systems. J Comp Neurol 402 460-474 1998.
Burdyga G Spiller D Morris R Lal S Th ompson DG Saeed S Dimaline R Varro A Dockray GJ. Expression of the leptin receptor in rat and human nodose ganglion neurones. Neuroscience 109 339-347 2002.
Burdyga G Lal S Spiller D Jiang W Thompson D Attwood S Saeed S Grundy D Varro A Dimaline R Dockray GJ. Localization of orexin-1 receptors to vagal aff erent neurons in the rat and humans. Gastroenterology 124 129-139 2003.
Cabral GA Griffin-Thomas L. Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinfl ammation. Expert Rev Mol Med 11 e3 2009.
Castaneda TR Tong J Datta R Culler M Tschop MH. Ghrelin in the regulation of body weight and metabolism Front Neuroendocrinol 31 44-60 2010.
Chen AS Marsh DJ Trumbauer ME Frazier EG Guan XM Yu H Rosenblum CI Vongs A Feng Y Cao L Metzger JM Strack AM Camacho RE Mellin TN Nunes CN Min W Fisher J Gopal-Truter S MacIntyre DE Chen HY Van der Ploeg LH. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 26 97-102 2000.
Cohen MA Ellis SM Le Roux CW Batterham RL Park A Patterson M Frost GS Ghatei MA Bloom SR. Oxyntomodulin suppresses appetite and reduces food intake in humans. J Clin Endocrinol Metab 88 4696-4701 2003.
Cone RD. Anatomy and regulation of the central melanocortin system. Nat Neurosci 8 571-578 2005.
Considine RV Sinha MK Heiman ML Kriauciunas A Stephens TW Nyce MR Ohannesian JP Marco CC McKee LJ Bauer TL. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. New Eng J Med 334 292-295 1996.
Coope A Milanski M Araujo EP Tambascia M Saad MJ Geloneze B Velloso LA. AdipoR1 mediates the anorexigenic and insulin/leptin-like actions of adiponectin in the hypothalamus. FEBS Lett 582 1471-1476 2008.
Costantini VJ Vicentini E Sabbatini FM Valerio E Lepore S Tessari M Sartori M Michielin F Melotto S Bifone A Pich EM Corsi M. GSK1614343 a novel ghrelin receptor antagonist produces an unexpected increase of food intake and body weight in rodents and dogs. Neuroendocrinol 94 158-68 2011.
Cota D Marsicano G Tschop M Grubler Y Flachskamm C Schubert M Auer D Yassouridis A Thone-Reineke C Ortmann S Tomassoni F Cervino C Nisoli E Linthorst AC Pasquali R Lutz B Stalla GK Pagotto U. The endogenous cannabinoid system aff ects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112 423-431 2003.
Cota D Tschop MH Horvath TL Levine AS. Cannabinoids opioids and eating behavior: the molecular face of hedonism? Brain Res Rev 51 85-107 2006.
Cowley MA Smith RG Diano S Tschop M Pronchuk N Grove KL Strasburger CJ Bidlingmaier M Esterman M Heiman ML Garcia-Segura LM Nillni EA Mendez P Low MJ Sotonyi P Friedman JM Liu H Pinto S Colmers WF Cone RD Horvath TL. Th e distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37 649-661 2003.
Cummings DE Overduin J. Gastrointestinal regulation of food intake. J Clin Invest 117 13-23 2007.
Dakin CL Small CJ Batterham RL Neary NM Cohen MA Patterson M Ghatei MA Bloom SR. Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinol 145 2687-2695 2004.
Date Y Murakami N Toshinai K Matsukura S Niijima A Matsuo H Kangawa K Nakazato M. The role of the gastric aff erent vagal nerve in ghrelin induced feeding and growth hormone secretion in rats. Gastroenterology 123 1120-1128 2002.
Date Y. Ghrelin and the vagus nerve. Methods in Enzymology 514 261-269 2012.
de Graaf C Blom WA Smeets PA Stafl eu A Hendriks HF. Biomarkers of satiation and satiety. A J Clin Nutr 79 946-961 2004.
Devane WA Manus L Breuer A Pertwee RG Stevenson LA Griffi n G Gibson D Mandelbaum A Etinger A Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258 1946-1949 1992.
Dhuria SV Fine JM Bingham D Svitak AL Burns RB Baillargeon AM Panter SS Kazi AN Frey WH 2nd Hanson LR. Food consumption and activity levels increase in rats following intranasal Hypocretin-1. Neurosci Lett 627 155-159 2016.
Di Marzo V Bisogno T De Petrocellis L Melck D Orlando P Wagner JA Kunos G. Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur J Biochem 264 258-267 1999.
Di Marzo V Matias I. Endocannabinoid control of food intake and energy balance. Nat Neurosci 8 585-589 2005.
Dube MG Kalra SP Kalra PS. Food intake elicited by administration of orexins/hypocretins: identifi cation of hypothalamic sites of action. Brain Res 842 473-477 1999.
Fehmann HC Jiang J Schweinfurth J Wheeler MB Boyd AE 3rd Goke B. Stable expression of the rat GLP-I receptor in CHO cells: activation and binding characteristics utilizing GLP-I(7-36)-amide oxyntomodulin exendin- 4 and exendin(9-39). Peptides 15 453-456 1994.
Foster-Schubert KE Cummings DE. Emerging therapeutic strategies for obesity. Endocr Rev 27 779-793 2006.
Fraley GS Scarlett JM Shimada I Teklemichael DN Acohido BV Clift on DK Steiner RA. Eff ects of diabetes and insulin on the expression of Galanin-like peptide in the hypothalamus of the rate. Diabetes 53 1237-1242 2004.
Friedman JM. Modern science versus the stigma of obesity. Nat Med 10 563-569 2004.
Fujimoto K Fukagawa K Sakata T Tso P. Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats. J Clin Invest 91 1830-1833 1993.
Galic S Oakhill JS Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol 316 129-139 2010.
Garruti G Cotecchia S Giampetruzzi F Giorgino F Giorgino R. Neuroendocrine deregulation of food intake adipose tissue and the gastrointestinal system in obesity and metabolic syndrome. J Gastrointestin Liver Dis 17 193-198 2008.
Gauthier KM Baewer DV Hittner S Hillard CJ Nithipatikom K Reddy DS Falck JR Campbell WB. Endotheliumderived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries. Am J Physiol Heart Circ Physiol 288 H1344-H1351 2005.
Geary N Le Sauter J Noh U. Glucagon acts in the liver to control spontaneous meal size in rats. Am J Physiol 264 R116-R122 1993.
Gerozissis K. Brain insulin and feeding: a bi-directional communication. Eur J Pharmacol 490 59-70 2004.
Ghatei MA Uttenthal LO Christofides ND Bryant MG Bloom SR. Molecular forms of human enteroglucagon in tissue and plasma: plasma responses to nutrient stimuli in health and in disorders of the upper gastrointestinal tract. J Clin Endocrinol Metab 57 488-495 1983.
Gonthier MP Hoareau L Festy F Matias I Valenti M Bes-Houtmann S Rouch C Robert-Da Silva C Chesne S Lefebvre d’Hellencourt C Cesari M Di Marzo V Roche R. Identifi cation of endocannabinoids and related compounds in human fat cells. Obesity 15 837-845 2007.
Goodman A. Neurobiology of addiction. An integrative review. Biochem Pharmacol 75 266-322 2008.
Halmos T Suba I. Role of the brain in the regulation of metabolism and energy expenditure: the central role of insulin and insulin resistance of the brain. Orv Hetil 152 83-91 2011.
Hankir MK Parkinson JR Minnion JS Addison ML Bloom SR Bell JD. Peptide YY 3-36 and pancreatic polypeptide diff erentially regulate hypothalamic neuronal activity in mice in vivo as measured by manganese-enhanced magnetic resonance imaging. J Neuroendocrinol 23 371-380 2011.
Hare KJ. Role of GLP-1 induced glucagon suppression in type 2 diabetes mellitus. Dan Med Bull 57 B4181 2010.
Hargrave SL Kinzig KP. Repeated gastric distension alters food intake and neuroendocrine profi les in rats. Physiol Behav 105 975-981 2012.
Herisson FM Waas JR Fredriksson R Schioth HB Levine AS Olszewski PK. Oxytocin acting in the nucleus accumbens core decreases food intake. J Neuroendocrinol 28 2016.
Hillebrand JJ Geary N. Do leptin and insulin signal adiposity? Forum Nutr 63 111-122 2010.
Hirako S Wada N Kageyama H Takenoya F Izumida Y Kim H Iizuka Y Matsumoto A Okabe M Kimura A Suzuki M Yamanaka S Shioda S. Autonomic nervous system-mediated eff ects of galanin-like peptide on lipid metabolism in liver and adipose tissue. Sci Rep 6 21481 2016.
Hoebel BG. Brain neurotransmitters in food and drug reward. Am J Clin Nutr 42 1133-1150 1985.
Holst JJ. On the physiology of GIP and GLP-1. Horm Metab Res 36 747-754 2004.
Honda K Kamisoyama H Saito N Kurose Y Sugahara K Hasegawa S. Central administration of glucagon suppresses food intake in chicks. Neurosci Lett 416 198-201 2007.
Horvath TL. Endocannabinoids and the regulation of body fat: the smoke is clearing. J Clin Invest 112 323-326 2003.
Hotta M Shibasaki T Arai K Demura H. Corticotropin-releasing factor receptor type 1 mediates emotional stressinduced inhibition of food intake and behavioral changes in rats. Brain Res 823 221-225 1999.
Hou J Zheng DZ Zhou JY Zhou SW. Orexigenic eff ect of cocaine- and amphetamine-regulated transcript (CART) aft er injection into hypothalamic nuclei in streptozotocin-diabetic rats. Clin Exp Pharmacol Physiol 37 989-995 2010.
Huszar D Lynch CA Fairchild-Huntress V Dunmore JH Fang Q Berkemeier LR Gu W Kesterson RA Boston BA Cone RD Smith FJ Campfi eld LA Burn P Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88 131-134 1997.
Iwasaki Y Kakei M Nakabayashi H Ayush EA Hirano-Kodaira M Maejima Y Yada T. Pancreatic polypeptide and peptide YY3-36 induce Ca2+ signaling in nodose ganglion neurons. Neuropeptides 47 19-23 2013.
Jamshidi N Taylor DA. Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br J Pharmacol 134 1151-1154 2001.
Jbilo O Ravinet-Trillou C Arnone M Buisson I Bribes E Peleraux A Penarier G Soubrie P Le Fur G Galiegue S Casellas P. Th e CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance. FASEB J19 1567-1569 2005.
Jequier E Tappy L. Regulation of body weight in humans. Physiol Rev 79 451-480 1999.
Jesudason DR Monteiro MP McGowan BM Neary NM Park AJ Philippou E Small CJ Frost GS Ghatei MA Bloom SR. Low-dose pancreatic polypeptide inhibits food intake in man. Br J Nutr 97 426-429 2007.
Kageyama H Shiba K Hirako S Wada N Yamanaka S Nogi Y Takenoya F Nonaka N Hirano T Inoue S Shioda S. Anti-obesity eff ect of intranasal administration of galanin-like peptide (GALP) in obese mice. Sci Rep 6 28200 2016.
Katayama S Tomonaga S Sato M Yamane H Tsuneyoshi Y Denbow DM Furuse M. Norepinephrine does not alter NPY and POMC mRNA expression in neonatal chicks. Comp Biochem Physiol A Mol Integr Physiol 156 143-146 2010.
Keenan GS Brunstrom JM Ferriday D. Eff ects of meal variety on expected satiation: evidence for a ‘perceived volume’ heuristic. Appetite 89 10-15 2015.
Kenny PJ. Common cellular and molecular mechanisms in obesity and drug addiction. Nat Rev Neurosci 12 638- 651 2011.
Kim ER Mizuno TM. Role of neurotensin receptor 1 in the regulation of food intake by neuromedins and neuromedin- related peptides. Neurosci Lett 468 64-67 2010.
Klok MD Jakobsdottir S Drent ML. Th e role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev 8 21-34 2007.
Kogan NM Mechoulam R. Th e chemistry of endocannabinoids. J Endocrinol Invest 29 3-14 2006.
Kola B Farkas I Christ-Crain M Wittmann G Lolli F Amin F Harvey-White J Liposits Z Kunos G Grossman AB Fekete C Korbonits M. Th e orexigenic eff ect of ghrelin is mediated through central activation of the endogenous cannabinoid system. PLoS One 3 e1797 2008.
Koren MS Holmes MD. Vagus nerve stimulation does not lead to signifi cant changes in body weight in patients with epilepsy. Epilepsy Behav 8 246-249 2006.
Kristensen P Judge ME Th im L Ribel U Christjansen KN Wulff BS Clausen JT Jensen PB Madsen OD Vrang N Larsen PJ Hastrup S. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393 72-76 1998.
Krude H Biebermann H Luck W Horn R Brabant G Gruters A. Severe early-onset obesity adrenal insuffi ciency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19 155-157 1998.
Lateef DM Washington MC Raboin SJ Roberson AE Mansour MM Williams CS Sayegh AI. Duodenal myotomy blocks reduction of meal size and prolongation of intermeal interval by cholecystokinin. Physiol Behav 105 829-834 2012.
Lawrence C Fraley GS. Galanin-like peptide (GALP) is a hypothalamic regulator of energy homeostasis and reproduction. Front Neuroendocrinol 32 1-9 2011.
Lawson EA Marengi DA DeSanti RL Holmes TM Schoenfeld DA Tolley CJ. Oxytocin reduces caloric intake in men. Obesity (Silver Spring) 23 950-956 2015.
le Roux CW Batterham RL Aylwin SJ Patterson M Borg CM Wynne KJ Kent A Vincent RP Gardiner J Ghatei MA Bloom SR. Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 147 3-8 2006.
Lee H K Choi EB Pak CS. Th e current status and future perspectives of studies of cannabinoid receptor 1 antagonists as anti-obesity agents. Curr Top Med Chem 9 482-503 2009.
Leibowitz SF. Paraventricular nucleus: a primary site mediating adrenergic stimulation of feeding and drinking. Pharmacol Biochem Behav 8 163-175 1978.
Liddle RA Goldfine ID Rosen MS Taplitz RA Williams JA. Cholecystokinin bioactivity in human plasma. Molecular forms responses to feeding and relationship to gallbladder contraction. J Clin Invest 75 1144-1152 1985.
Lin S Boey D Herzog H. NPY and Y receptors: lessons from transgenic and knockout models. Neuropeptides 38 189-200 2004.
Lin S Shi YC Yulyaningsih E Aljanova A Zhang L Macia L Nguyen AD Lin EJ During MJ Herzog H Sainsbury A. Critical role of arcuate Y4 receptors and the melanocortin system in pancreatic polypeptide-induced reduction in food intake in mice. PLoS One 4 e8488 2009.
Little TJ Pilichiewicz AN Russo A Phillips L Jones KL Nauck MA Wishart J Horowitz M Feinle-Bisset C. Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses. J Clin Endocrinol Metab 91 1916-1923 2006.
Lutz TA. Control of food intake and energy expenditure by amylin-therapeutic implications. Int J Obes (Lond) 33 S24-S27 2009.
Maejima T Hashimoto K Yoshida T Aiba A Kano M. Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron 31 463-475 2001.
Martin CK Bellanger DE Rau KK Coulon S Greenway FL. Safety of the Ullorex oral intragastric balloon for the treatment of obesity. J Diabetes Sci Technol 1 574-581 2007.
Martin KA Mani MV Mani A. New targets to treat obesity and the metabolic syndrome. Eur J Pharmacol 763 64-74 2015.
Mastorakos G Zapanti E. Th e hypothalamic-pituitary-adrenal axis in the neuroendocrine regulation of food intake and obesity: the role of corticotropin releasing hormone. Nutr Neurosci 7 271-280 2004.
Matias I Bisogno T Di Marzo V. Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake. Int J Obes (Lond) 30 S7-S12 2006.
Matsuda K Kojima K Shimakura S Wada K Maruyama K Uchiyama M Kikuyama S Shioda S. Corticotropinreleasing hormone mediates α-melanocyte-stimulating hormone-induced anorexigenic action in goldfish. Peptides 29 1930-1936 2008.
McGowan MK Andrews KM Grossman SP. Chronic intrahypothalamic infusions of insulin or insulin antibodies alter body weight and food intake in the rat. Physiol Behav 51 753-766 1992.
Mechoulam R Ben-Shabat S Hanus L Ligumsky M Kaminski NE Schatz AR Gopher A Almog S Martin BR Compton DR Pertwee RG Griffi n G Bayewitch M Barg J Vogel Z. Identifi cation of an endogenous 2-monoglyceride present in canine gut that binds to cannabinoid receptors. Biochem Pharmacol 50 83-90 1995.
Meguid MM Glade MJ Middleton FA. Weight regain aft er Roux-en-Y: a signifi cant 20% complication related to PYY. Nutrition 24 832-842 2008.
Mentlein R Gallwitz B Schmidt WE. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide glucagonlike peptide-1(7-36) amide peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem 214 829-835 1993.
Meyer-Lindenberg A Domes G Kirsch P Heinrichs M. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci 12 524-538 2011.
Mihaly E Fekete C Legradi G Lechan RM. Hypothalamic dorsomedial nucleus neurons innervate thyrotropinreleasing hormone- synthesizing neurons in the paraventricular nucleus. Brain Res 891 20-31 2001.
Moore CJ Johnson ZP Higgins M Toufexis D Wilson ME. Antagonism of corticotrophin-releasing factor type 1 receptors attenuates caloric intake of free feeding subordinate female rhesus monkeys in a rich dietary environment. J Neuroendocrinol 27 33-43 2015.
Moran TH Baldessarini AR Salorio CF Lowery T Schwartz GJ. Vagal aff erent and eff erent contributions to the inhibition of food intake by cholecystokinin. Am J Physiol 272 R1245-R1251 1997.
Moran TH Katz LF Plata-Salaman CR Schwartz GJ. Disordered food intake and obesity in rats lacking cholecystokinin A receptors. Am J Physiol 274 R618-R625 1998.
Moriarty P Dimaline R Thompson DG Dockray GJ. Characterization of cholecystokininA and cholecystokininB receptors expressed by vagal aff erent neurons. Neuroscience 79 905-913 1997.
Morton GJ Thatcher BS Reidelberger RD Ogimoto K Wolden-Hanson T Baskin DG Schwartz MW Blevins JE. Peripheral oxytocin suppresses food intake and causes weight loss in diet-induced obese rats. Am J Physiol Endocrinol Metab 302 E134-E144 2012.
Nakagawa A Satake H Nakabayashi H Nishizawa M Furuya K Nakano S Kigoshi T Nakayama K Uchida K. Receptor gene expression of glucagon-like peptide-1 but not glucose-dependent insulinotropic polypeptide in rat nodose ganglion cells. Auton Neurosci 110 36-43 2004.
Nelson DW Sharp JW Brownfield MS Raybould HE Ney DM. Localization and activation of glucagon-like peptide-2 receptors on vagal aff erents in the rat. Endocrinology 148 1954-1962 2007.
Nogueiras R Veyrat-Durebex C Suchanek PM Klein M Tschop J Caldwell C Woods SC Wittmann G Watanabe M Liposits Z Fekete C Reizes O Rohner-Jeanrenaud F Tschop MH. Peripheral but not central CB1 antagonism provides food intake-independent metabolic benefi ts in diet-induced obese rats. Diabetes 57 2977-2991 2008.
Nutt DJ Lingford-Hughes A Erritzoe D Stokes PR. The dopamine theory of addiction: 40 years of highs and lows. Nat Rev Neurosci 16 305-312 2015.
Ochner CN Barrios DM Lee CD Pi-Sunyer FX. Biological mechanisms that promote weight regain following weight loss in obese humans. Physiol Behav 15 106-113 2013.
Okada S York DA Bray GA Mei J Erlanson-Albertsson C. Diff erential inhibition of fat intake in two strains of rat by the peptide enterostatin. Am J Physiol 262 R1111-R1116 1992.
Ott V Finlayson G Lehnert H Heitmann B Heinrichs M Born J Hallschmid M. Oxytocin reduces reward-driven food intake in humans. Diabetes 62 3418-3425 2013.
Overduin J Gibbs J Cummings DE Reeve JR Jr. CCK-58 elicits both satiety and satiation in rats while CCK-8 elicits only satiation. Peptides 54 71-80 2014.
Pagano C Rossato M Vettor R. Endocannabinoids adipose tissue and lipid metabolism. J Neuroendocrinol 20 124-129 2008.
Pagotto U Marsicano G Cota D Lutz B Pasquali R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev 27 73-100 2006.
Palmiter RD. Is dopamine a physiologically relevant mediator of feeding behavior? Trends Neurosci 30 375-381 2007.
Parker JA McCullough KA Field BC Minnion JS Martin NM Ghatei MA Bloom SR. Glucagon and GLP-1 inhibit food intake and increase c-fos expression in similar appetite regulating centres in the brainstem and amygdala. Int J Obes (Lond) 37 1391-1398 2013.
Paz-Filho GJ Volaco A Suplicy HL Radominski RB Boguszewski CL. Decrease in leptin production by the adipose tissue in obesity associated with severe metabolic syndrome. Arq Bras Endocrinol Metabol 53 1088-1095 2009.
Pelleymounter MA Cullen MJ Wellman CL. Characteristics of BDNF-induced weight loss. Exp Neurol 131 229-238 1995.
Pfluger PT Kampe J Castaneda TR Vahl T D’Alessio DA Kruthaupt T Benoit SC Cuntz U Rochlitz HJ Moehlig M Pfeiff er AF Koebnick C Weickert MO Otto B Spranger J Tschop MH. Eff ect of human body weight changes on circulating levels of peptide YY and peptide YY3-36. J Clin Endocrinol Metab 92 583-588 2007.
Pocai A Carrington PE Adams JR Wright M Eiermann G Zhu L Du X Petrov A Lassman ME Jiang G Liu F Miller C Tota LM Zhou G Zhang X Sountis MM Santoprete A Capito’ E Chicchi GG Th ornberry N Bianchi E Pessi A Marsh DJ SinhaRoy R. Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice. Diabetes 58 2258-2266 2009.
Pomorska DK do-Rego JC do-Rego JL Zubrzycka M Janecka A. Opioid and cannabinoid system in food intake. Curr Pharm Des 22 1361-1370 2016.
Potes CS Turek VF Cole RL Vu C Roland BL Roth JD Riediger T Lutz TA. Noradrenergic neurons of the area postrema mediate amylin’s hypophagic action. Am J Physiol Regul Integr Comp Physiol 299 R623-R631 2010.
Pothos EN Hernandez L Hoebel BG. Chronic food deprivation decreases extracellular dopamine in the nucleus accumbens: implications for a possible neurochemical link between weight loss and drug abuse. Obes Res 3 525S-529S 1995.
Powley TL Chi MM Baronowsky EA Phillips RJ. Gastrointestinal tract innervation of the mouse: aff erent regeneration and meal patterning aft er vagotomy. Am J Physiol Regul Integr Comp Physiol 289 R563-R574 2005.
Qin X Tso P. Th e role of apolipoprotein AIV in the control of food intake. Curr Drug Targets 6 145-151 2005.
Quarta C Bellocchio L Mancini G Mazza R Cervino C Braulke LJ Fekete C Latorre R Nanni C Bucci M Clemens LE Heldmaier G Watanabe M Leste-Lassere T Maitre M Tedesco L Fanelli F Reuss S Klaus S Srivastava RK Monory K Valerio A Grandis A De Giorgio R Pasquali R Nisoli E Cota D Lutz B Marsicano G Pagotto U. CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance. Cell Metab 11 273-285 2010.
Quarta C Mazza R Obici S Pasquali R Pagotto U. Energy balance regulation by endocannabinoids at central an peripheral levels. Trends Mol Med 17 518-526 2011.
Raffan E Dennis RJ O’Donovan CJ Becker JM Scott RA Smith SP Withers DJ Wood CJ Conci E Clements DN Summers KM German AJ Mellersh CS Arendt ML Iyemere VP Withers E Soder J Wernersson S Andersson G Lindblad-Toh K Yeo GS O’Rahilly S. A Deletion in the canine POMC gene is associated with weight and appetite in obesity-prone labrador retriever dogs. Cell Metab 23 893-900 2016.
Ratner C Skov LJ Raida Z Bachler T Bellmann-Sickert K Le Foll C Sivertsen B Dalboge LS Hartmann B Beck-Sickinger AG Madsen AN Jelsing J Holst JJ Lutz TA Andrews ZB Holst B. Eff ects of peripheral neurotensin on appetite regulation and its role in gastric bypass surgery. Endocrinology 157 3482-3492 2016.
Ravinet Trillou C Delgorge C Menet C Arnone M Soubrie P. CB1 cannabinoid receptor knockout in mice leads to leanness resistance to diet induced obesity and enhanced leptin sensitivity. Int J Obes Relat Metab Disord 28 640-648 2004.
Rehfeld JF. Th e new biology of gastrointestinal hormones. Physiol Rev 78 1087-1108 1998.
Riedy CA Chavez M Figlewicz DP Woods SC. Central insulin enhances sensitivity to cholecystokinin. Physiol Behav 58 755-760 1995.
Ritter RC. Gastrointestinal mechanisms of satiation for food. Physiol Behav 81 249-273 2004.
Rohner-Jeanrenaud F Craft LS Bridwell J Suter TM Tinsley FC Smiley DL Burkhart DR Statnick MA Heiman ML Ravussin E Caro JF. Chronic central infusion of cocaine- and amphetamine-regulated transcript (CART 55-102): eff ects on body weight homeostasis in lean and high-fat-fed obese rats. Int J Obes Relat Metab Disord 26 143-149 2002.
Rorato R Miyahara C Antunes-Rodrigues J Elias LL. Tolerance to hypophagia induced by prolonged treatment with a CB1 antagonist is related to the reversion of anorexigenic neuropeptide gene expression in the hypothalamus. Regul Pept 182 12-18 2013.
Roth JD Hughes H Kendall E Baron AD Anderson CM. Antiobesity eff ects of the beta-cell hormone amylin in diet-induced obese rats: eff ects on food intake body weight composition energy expenditure and gene expression. Endocrinology 147 5855-5864 2006.
Sandoval D Cota D Seeley RJ. Th e integrative role of CNS fuel-sensing mechanisms in energy balance and glucose regulation. Annu Rev Physiol 70 513-535 2008.
Santoso P Maejima Y Kumamoto K Takenoshita S Shimomura K. Central action of ELABELA reduces food intake and activates arginine vasopressin and corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus. Neuroreport 26 820-826 2015.
Sawchenko PE Swanson LW. Localization localization and plasticity of corticotropin-releasing factor immunoreactivity in rat brain. Fed Proc 44 221-227 1985.
Scheen AJ Van Gaal LG Despres JP Pi-Sunyer X Golay A Hanotin C. Rimonabant improves cardiometabolic risk profi le in obese or overweight subjects: overview of RIO studies. Rev Med Suisse 2 1916-1923 2006.
Schwartz GJ. Th e role of gastrointestinal vagal aff erents in the control of food intake: current prospects. Nutrition 16 866-873 2000.
Schwartz GJ. Brainstem integrative function in the central nervous system control of food intake. Forum Nutr 63 141-151 2010.
Sekino A Ohata H Mano-Otagiri A Arai K Shibasaki T. Both corticotropin-releasing factor receptor type 1 and type 2 are involved in stress-induced inhibition of food intake in rats. Psychopharmacology 176 30-38 2004.
Silvestri C Di Marzo V. Th e endocannabinoid system in energy homeostasis and the etiopathology of metabolic
disorders. Cell Metab 17 475-490 2013.
Simpson CW Dicara L. Estradiol Inhibition of Catecholamine Elicited Eating in the Female Rat. Pharmacol Biochem Behav 1 413-419 1973.
Smith GP. Satiation: from gut to brain. Oxford University Press New York USA. PP 291 1998.
Sterl K Wang S Oestricker L Wallendorf MJ Patterson BW Reeds DN Wice BM. Metabolic responses to xenin-25 are altered in humans with Roux-en-Y gastric bypass surgery. Peptides 82 76-84 2016.
Strubbe JH Woods SC. Th e timing of meals. Psychol Rev 111 128-141 2004.
Sun Y Wang P Zheng H Smith RG. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci U S A 101 4679-4684 2004.
Suzuki K Simpson K A Minnion JS Shillito JC Bloom SR. Th e role of gut hormones and the hypothalamus in appetite regulation. Endocrinol J 57 359-372 2010.
Takenoya F Hirayama M Kageyama H Funahashi H Kita T Matsumoto H Ohtaki T Katoh S Takeuchi M Shioda S. Neuronal interactions between galanin-like-peptide- and orexin- or melanin-concentrating hormonecontaining neurons. Regul Pept 126 79-83 2005.
Talsania T Anini Y Siu S Drucker DJ Brubaker PL. Peripheral exendin-4 and peptide YY (3-36) synergistically reduce food intake through diff erent mechanisms in mice. Endocrinology 146 3748-3756 2005.
Tam J Vemuri VK Liu J Batkai S Mukhopadhyay B Godlewski G Osei-Hyiaman D Ohnuma S Ambudkar SV Pickel J Makriyannis A Kunos G. Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity. J Clin Invest 120 2953-6629 2010.
Tanda G Di Chiara G. A dopamine- ⊠1 opioid link in the rat ventral tegmentum shared by palatable food (Fonzies) and non-psychostimulant drugs of abuse. Eur J Neurosci 10 1179-1187 1998.
Tedesco L Valerio A Cervino C Cardile A Pagano C Vettor R Pasquali R Carruba MO Marsicano G Lutz B Pagotto U Nisoli E. Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes. Diabetes 57 2028-2036 2008.
Thienel M Fritsche A Heinrichs M Peter A Ewers M Lehnert H Born J Hallschmid M. Oxytocin’s inhibitory eff ect on food intake is stronger in obese than normal-weight men. Int J Obes (Lond) 40 1707-1714 2016.
Trujillo ME Scherer PE. Adipose tissue-derived factors: impact on health and disease. Endocr Rev 27 762-778 2006.
Tso P Sun W Liu M. Gastrointestinal satiety signals IV. Apolipoprotein A-IV. Am J Physiol Gastrointest Liver Physiol 286 G885-G890 2004.
Verty AN McGregor IS Mallet PE. Paraventricular hypothalamic CB (1) cannabinoid receptors are involved in the feeding stimulatory eff ects of Delta (9)-tetrahydrocannabinol. Neuropharmacology 49 1101-1109 2005.
Verty AN Boon WM Mallet PE McGregor IS Oldfi eld BJ. Involvement of hypothalamic peptides in the anorectic action of the CB receptor antagonist rimonabant (SR 141716). Eur J Neurosci 29 2207-2216 2009.
Verty AN Stefanidis A McAinch AJ Hryciw DH Oldfield B. Anti-obesity eff ect of the CB2 receptor agonist JWH- 015 in diet-induced obese mice. PLoS One 10 e0140592 2015.
Volkow ND Wang GJ Baler RD. Reward dopamine and the control of food intake: implications for obesity. Trends Cogn Sci 15 37-46 2011.
Wallenius K Jansson JO Wallenius V. Th e therapeutic potential of interleukin-6 in treating obesity. Expert Opin Biol Th er 3 1061-1070 2003.
Washington MC Coggeshall J Sayegh AI. Cholecystokinin-33 inhibits meal size and prolongs the subsequent intermeal interval. Peptides 32 971-977 2011.
Whitcomb DC Puccio AM Vigna SR Taylor IL Hoffman GE. Distribution of pancreatic polypeptide receptors in the rat brain. Brain Res 760 137-149 1997.
Wielinga PY Alder B Lutz TA. Th e acute eff ect of amylin and salmon calcitonin on energy expenditure. Physiol Behav 91 212-217 2007.
Wodowska J Ciosek J. [Galanin-like peptide (GALP): localization receptors and biological function]. Postepy Hig Med Dosw (Online) 69 1067-1076 2015.
Woods SC Lotter EC McKay LD Porte D Jr. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 282 503-505 1979.
Woods SC Seeley RJ Baskin DG Schwartz MW. Insulin and the blood-brain barrier. Curr Pharm Des 9 795-800 2003.
Woods SC. Signals that infl uence food intake and body weight. Physiol Behav 86 709-716 2005.
Wynne K Stanley S McGowan B Bloom S. Appetite control. J Endocrinol 184 291-318 2005.
Wynne K Park AJ Small CJ Meeran K Ghatei MA Frost GS Bloom SR. Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obesehumans: a randomized controlled trial. Int J Obes (Lond) 30 1729-1736 2006.
Xu B Goulding EH Zang K Cepoi D Cone RD Jones KR Tecott LH Reichardt LF. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci 6 736-742 2003.
Young A Denaro M. Roles of amylin in diabetes and in regulation of nutrient load. Nutrition 14 524-527 1998.
Yu Y South T Wang Q Huang XF. Diff erential expression of hypothalamic CART mRNA in response to body weight change following diff erent dietary interventions. Neurochem Int 52 1422-1430 2008.
Zac-Varghese S Tan T Bloom SR. Hormonal interactions between gut and brain. Discov Med 10 543-552. 2010.
Zhang H Wu C Chen Q Chen X Xu Z Wu J Cai D. Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models. PLoS One 8 e61477 2013.